why choose us

First received: December 07, 2023

Clinical Trial: A Study to Learn How Safe Starting Vericiguat at a Dose of 5 Milligrams is in Participants With Chronic Heart Failure With Reduced Ejection Fraction

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Chronic Heart Failure With Reduced Ejection Fraction

Study Type: INTERVENTIONAL


Official Title: A Phase 2b Open-label Clinical Study to Evaluate the Tolerability and Safety of an Initiation Dose of 5 mg of Vericiguat in Participants With Chronic Heart Failure With Reduced Ejection Fraction

Brief Summary: Researchers are looking for a better way to treat people who have chronic heart failure with reduced ejection fraction.Chronic heart failure with reduced ejection fraction (HFrEF) is a long-term condition that occurs when the heart is too weak to pump enough blood to the rest of the body.This results in a reduced supply of the oxygen that the body requires to function properly.The common symptoms of HFrEF include breathlessness, weakness, fatigue, and swelling in the ankles and legs.If left untreated, heart…

Read more